Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.
포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.
터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
Valneva Reports Preliminary Unaudited 2024 Revenue and Cash and Provides 2025 Outlook Met 2024 growth targets for sales revenue (+13% vs 2023) and...
Met 2024 growth targets for sales revenue (+13% vs 2023) and total revenues (+10% vs 2023)Strong year-end cash...
Valneva publie son chiffre d’affaires et sa trésorerie non audités pour l’exercice 2024 et fournit des indications préliminaires pour l’exercice...
Shareholding declaration Valneva SE - January 2025 VALNEVA Declaration of shares and voting rights January 31, 2025_______________________________...
Déclaration d'actions et de droits de vote de la société Valneva SE - Janvier 2025 VALNEVA Déclaration d’actions et de droits de vote 31...
Valneva reçoit une autorisation de mise sur le marché au Royaume-Uni pour le premier vaccin au monde contre le chikungunya, IXCHIQ® Saint Herblain...
Valneva Receives Marketing Authorization in the UK for the World’s First Chikungunya Vaccine, IXCHIQ® Saint Herblain (France), February 5, 2025 –...
Saint Herblain (France), February 5, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine...
Valneva annonce un nouveau contrat d’une valeur minimale de $32.8 millions avec le gouvernement américain pour la fourniture de son vaccin IXIARO®...
Valneva Announces New IXIARO® Supply Contract with the U.S. Government Worth a Minimum of $32.8 Million Saint Herblain (France), January 30, 2025...
Saint Herblain (France), January 30, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine...
Valneva Reports Positive Phase 2 Results in Children for its Chikungunya Vaccine and Announces Phase 3 Dose Decision Saint-Herblain (France...
Valneva annonce des résultats de Phase 2 positifs chez les enfants pour son vaccin contre le chikungunya ainsi que la dose sélectionnée pour la...
Saint-Herblain (France), January 22, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) today announced...
Valneva Reports High Sustained Immune Response in Adolescents One Year After Single Vaccination with its Chikungunya Vaccine Saint-Herblain...
귀하가 조회한 주식이 이 박스에 나타나며 쉽게 최근 시세로 돌아갈 수 있습니다.
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관
광고 없는 경험을 위해 가입하세요
지금 사용해 보세요
광고 유지